Aytu BioPharma, Inc (AYTU) stock
AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 22, 2026Score 9/3079% below fair value
$1.78−0.01 (-0.56%)
Close on Nov 13, 2026Market cap $19.34MP/E –Yield –
Aytu BioPharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Aytu BioPharma's enterprise value was $4.07M on Nov 11, 2026, against $1.38M a year earlier. Over the last 5 years it ranged from -$1.32M to $19.01M, with a median of $8.27M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.07M | -25.3% |
| 2025 | Dec 31, 2025 | $5.44M | -21.1% |
| 2024 | Dec 31, 2024 | $6.90M | -41.8% |
| 2023 | Dec 29, 2023 | $11.86M | +367.8% |
| 2022 | Dec 30, 2022 | $2.54M | -81.7% |
| 2021 | Dec 31, 2021 | $13.85M | -63.8% |
| 2020 | Dec 31, 2020 | $38.27M | +267.0% |
| 2019 | Dec 31, 2019 | $10.43M | – |
| 2018 | Dec 31, 2018 | -$2.54M | -209.4% |
| 2017 | Dec 29, 2017 | $2.32M | -30.0% |
| 2016 | Dec 30, 2016 | $3.32M | -92.4% |
| 2015 | Dec 31, 2015 | $43.93M | +24233.4% |
| 2014 | Dec 31, 2014 | $180.54K | -46.0% |
| 2013 | Dec 31, 2013 | $334.14K | -50.3% |
| 2012 | Dec 31, 2012 | $671.89K | +102.4% |
| 2011 | Dec 30, 2011 | $332.01K | – |
See a number that looks wrong?